Cincinnati Financial (CINF) Q4 2024 Earnings Call Transcript
Operator Good morning, and welcome to the Cincinnati Financial fourth-quarter and full-year 2024 earnings conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the conference over to Dennis McDaniel,
Coca-Cola (KO) Q4 2024 Earnings Call Transcript
At this time, I'd like to welcome everyone to The Coca-Cola Company's fourth-quarter and full-year 2024 earnings results conference call. Today's call is being recorded. [Operator instructions] I would like to remind everyone that the purpose of this conference is to talk with investors,
Earnings call transcript: PennantPark misses Q4 2024 forecasts
PennantPark Investment Corporation (PNNT) reported its earnings for the fourth quarter of 2024, revealing a slight miss on both earnings per share (EPS) and revenue forecasts. The company reported an EPS of $0.
Marriott International (MAR) Q4 2024 Earnings Call Transcript
Marriott International Inc. ( NASDAQ: MAR) Q4 2024 Earnings Conference Call February 11, 2025 8:30 AM ET Anthony Capuano - President, Chief Executive Officer Leeny Oberg - Chief Financial Officer Jackie McConagha - Senior Vice President, Investor Relations
S&P; Global (SPGI) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Feb 11, 2025, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. Prep
Proto Labs (PRLB) Q4 2024 Earnings Call Transcript
Proto Labs (NYSE: PRLB) Q4 2024 Earnings Call Feb 07, 2025, 8:30 a.m. ET
Danaos Corporation (DAC) Q4 2024 Earnings Call Transcript
Danaos Corporation ( NYSE: DAC) Q4 2024 Earnings Conference Call February 11, 2025 9:00 AM ET Evangelos Chatzis - Chief Financial Officer John Coustas - Chief Executive Officer
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript
Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a listen-only mode. [Operator instructions] Please note, this event is being recorded.
Vertex Pharmaceuticals (VRTX) Misses Q4 Earnings Estimates
Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $3.98 per share, missing the Zacks Consensus Estimate of $3.99 per share. This compares to earnings of $4.20 per share a year ago. These figures are adjusted for non-recurring items.
Organigram (OGI) Q1 2025 Earnings Call Transcript
OGI earnings call for the period ending December 31, 2024. Organigram ( OGI -13.84%) Q1 2025 Earnings Call Feb 11, 2025, 8:00 ...
PetMed Express, Inc. (NASDAQ:PETS) Q3 2025 Earnings Call Transcript
Operator: Greetings and welcome to PetMed Express Third Quarter Financial Results Conference Call. At this time, all ...
Sonos (SONO) Q1 2025 Earnings Call Transcript
Sonos (NASDAQ: SONO) Q1 2025 Earnings Call Feb 06, 2025, 4:15 p.m. ET ...
Earnings call transcript: ProAct Q4 2023 sees revenue decline, positive outlook for 2025
ProAct, a $318 million market cap company, reported a decline in Q4 2023 revenue, with a 6.77% organic drop to SEK 1.3 billion. According to InvestingPro analysis, the stock appears undervalued ...
Radiant Logistics, Inc. (RLGT) Q2 2025 Earnings Call Transcript
Radiant Logistics, Inc. ( NYSE: RLGT) Q2 2025 Results Conference Call February 10, 2025 4:30 PM ET Elliot Alper - TD Cowen Mark Argento - Lake Street Capital Kevin Gainey - Thompson Davis Jeff ...